title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease,20240917T110000,https://www.globenewswire.com/news-release/2024/09/17/2947287/0/en/AC-Immune-Receives-Second-Milestone-Payment-Following-Progress-in-Phase-2b-ReTain-Trial-of-ACI-35-030-in-Preclinical-Alzheimer-s-Disease.html,JNJ,0.30021,Neutral,0.127876
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer's Disease - AC Immune  ( NASDAQ:ACIU ) ,20240917T110000,https://www.benzinga.com/pressreleases/24/09/g40895144/ac-immune-receives-second-milestone-payment-following-progress-in-phase-2b-retain-trial-of-aci-35-,JNJ,0.320784,Neutral,0.141189
"AC Immune's ACI-35.030  ( now ""JNJ-2056"" )  Granted FDA Fast Track Designation for Alzheimer's Disease",20240725T110000,https://www.globenewswire.com/news-release/2024/07/25/2918683/0/en/AC-Immune-s-ACI-35-030-now-JNJ-2056-Granted-FDA-Fast-Track-Designation-for-Alzheimer-s-Disease.html,JNJ,0.261117,Neutral,0.005879
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update,20240314T110000,https://www.globenewswire.com/news-release/2024/03/14/2846139/0/en/AC-Immune-Reports-Full-Year-2023-Financial-Results-and-Provides-a-Corporate-Update.html,JNJ,0.041682,Neutral,0.048052
"AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial",20231215T155843,https://www.benzinga.com/node/36256704,JNJ,0.401331,Somewhat-Bullish,0.165157
AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial - AC Immune  ( NASDAQ:ACIU ) ,20231215T122247,https://www.benzinga.com/pressreleases/23/12/g36255065/ac-immunes-targeted-anti-ptau-active-immunotherapy-for-alzheimers-disease-advances-into-phase-2b-t,JNJ,0.10607,Neutral,0.050182
AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial,20231215T122200,https://www.globenewswire.com/news-release/2023/12/15/2796982/0/en/AC-Immune-s-Targeted-Anti-pTau-Active-Immunotherapy-for-Alzheimer-s-Disease-Advances-into-Phase-2b-Trial.html,JNJ,0.081276,Neutral,0.050176
"Researchers return to Alzheimer's vaccines, buoyed by recent drug success",20231120T111500,https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-return-alzheimers-vaccines-buoyed-by-recent-drug-success-2023-11-20/,JNJ,0.041682,Somewhat-Bearish,-0.290871
Report Forecasts Promising Future for Alzheimer's Disease Market with New Therapeutic Approaches | Brandessence Market Research,20230515T093200,https://www.prnewswire.com/news-releases/report-forecasts-promising-future-for-alzheimers-disease-market-with-new-therapeutic-approaches--brandessence-market-research-301824407.html,JNJ,0.03478,Neutral,0.124339
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update,20230316T110000,https://www.globenewswire.com/news-release/2023/03/16/2628465/0/en/AC-Immune-Reports-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html,JNJ,0.017072,Neutral,0.072878
AC Immune's Alzheimer's Disease Vaccine-candidate ACI-35.030 Selected for Further Development,20221130T120000,https://www.globenewswire.com/news-release/2022/11/30/2564787/0/en/AC-Immune-s-Alzheimer-s-Disease-Vaccine-candidate-ACI-35-030-Selected-for-Further-Development.html,JNJ,0.035929,Neutral,0.056054
Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors,20240627T124955,https://www.benzinga.com/pressreleases/24/06/g39524015/treating-geographic-atrophy-remains-a-tough-call-for-ophthalmologists-as-they-voice-hesitancy-to-p,JNJ,0.045396,Somewhat-Bullish,0.21708
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,JNJ,0.013173,Neutral,0.026023
Clusters of monkeypox cases are driving up stock prices for some companies,20220523T195300,https://www.marketwatch.com/story/clusters-of-monkeypox-cases-are-driving-up-stock-prices-for-some-companies-11653335587,JNJ,0.092337,Neutral,-0.12754
3 Monkeypox Stocks That Soared Last Week,20220523T091300,https://www.fool.com/investing/2022/05/23/3-monkeypox-stocks-that-soared-last-week/,JNJ,0.05333,Bearish,-0.554367
"US-China Relations To Improve ""Very Shortly"", Examining The Micron ""Ban"", Full Truck & Kuaishou Beat",20230522T141625,https://www.forbes.com/sites/brendanahern/2023/05/22/us-china-relations-to-improve-very-shortly-examining-the-micron-ban-full-truck--kuaishou-beat/,JNJ,0.049322,Neutral,0.050443
